CPHI vs RF
China Pharma Holdings Inc (CPHI) versus RF (RF) — a side-by-side from cached financials, not a winner call.
China Pharma Holdings Inc (CPHI) is a drug manufacturers - specialty & generic company listed on US.
RF (RF) common stock.
Latest reported CPHI revenue for 2024-12-31 was $4.5M. Net income was -$4.7M. Revenue was down 35.4% from 2023-12-31 to 2024-12-31. CPHI currently screens at market cap $29.0M.
RF does not have a complete income-statement cache yet.
CPHI currently screens at market cap $29.0M. RF currently screens at market cap $0.
Not investment advice. Open the CPHI and RF stock pages for the full models.
Not investment advice.